Maria Rita Gulotta

Exploring the SARS-CoV-2 Proteome in the Search of Potential Inhibitors via Structure-Based Pharmacophore Modeling/Docking Approach

Giulia Culletta, Maria Rita Gulotta, Ugo Perricone et al. · Computation · 2020 · 38 citations · Full text

World Health Organization, Drug Target, Engineering +19

In Silico Insights towards the Identification of NLRP3 Druggable Hot Spots

Nedra Mekni, Maria De Rosa, Chiara Cipollina et al. · International Journal of Molecular Sciences · 2019 · 27 citations · Full text

A community effort in SARS‐CoV‐2 drug discovery

Johannes Schimunek, Philipp Seidl, Katarina Elez et al. · Molecular Informatics · 2023 · 17 citations · Full text

Community Effort, Drug Target, Billion Molecules +13

Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection

Anna Paola Carreca, Massimiliano Gaetani, Rosalia Busà et al. · Viruses · 2022 · 14 citations · Full text

Innate Immune System, Immunology, Immune Regulation +26

KUALA: a machine learning-driven framework for kinase inhibitors repositioning

Giada De Simone, Davide Stefano Sardina, Maria Rita Gulotta et al. · Scientific Reports · 2022 · 11 citations · Full text